Thus, a pathogenic calmodulin variant that binds CaV1.2 equally well as the WT will occupy some of the CaV1.2 binding sites without being able to properly respond to calcium signals to facilitate CDI. This evidence concerns the gene CACNA1C and clostridium difficile infection.